ChemBriefBioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis
Jul 31, 2026
BioNexus Gene Lab Corp (BGLC) reports a financial score of 6.04 despite a 98.93% year-over-year revenue drop to 22.84K. Net profit fell 12.79%, while several key operational metrics remain undisclosed.
2026-05-12
BioNexus Gene Lab Corp (BGLC)2026-07-26
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings2026-07-27
BioNexus Gene Lab Corp (BGLC) Cash FlowShow all 19 updates